Document is current
Any future updates will be listed below
-
Authors
Gobbi, Alessandro
Antonelli, Andrea
Dellaca, Raffaele
Pellegrino, Giulia M.
Pellegrino, Riccardo
Fredberg, Jeffrey J.
Solway, Julian
Brusasco, Vito
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 7 July 2024
First Online: 7 August 2024
Declarations
:
: The study has been approved by the S. Croce and Carle Hospital Ethics Committee, approval no. 40/13 of 19<sup>th</sup> April 2013. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: A.G. and R.D. are co-founders and serve as board members of RESTECH Srl, a company that designs, manufactures and sells devices for lung function testing based on Forced Oscillation Technique (FOT). R.D. also reports grants and other from RESTECH, personal fees from Philips Healthcare, outside the submitted work; In addition, R.D. has a patent on the detection of EFL by FOT with royalties paid to Philips Respironics and RESTECH Srl, a patent on monitoring lung volume recruitment by FOT with royalties paid to Vyaire, and a patent on early detection of exacerbations by home monitoring of FOT with royalties paid to RESTECH Srl. A.A., R.P., G.M. P., J.J.F., J.S, and VB have no conflict of interest related to the content of this manuscript.
